Tumor Suppressor p53 Stimulates the Expression of Epstein-Barr Virus Latent Membrane Protein 1
| Autor: | Qianli Wang, Zachary Kwapnoski, Amy Lingel, Vicki Geiser, Luwen Zhang |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Gene Expression Regulation
Viral 0301 basic medicine Herpesvirus 4 Human DNA damage Immunology Viral Oncogene Apoptosis Biology medicine.disease_cause Microbiology Virus Viral Matrix Proteins 03 medical and health sciences 0302 clinical medicine Cell Line Tumor Virology otorhinolaryngologic diseases medicine Humans Promoter Regions Genetic Gene knockdown Epstein–Barr virus latent membrane protein 1 Cell Transformation Viral Epstein–Barr virus Virus-Cell Interactions Virus Latency stomatognathic diseases 030104 developmental biology 030220 oncology & carcinogenesis Insect Science Interferon Regulatory Factors Cancer research Tumor Suppressor Protein p53 DNA Damage Interferon regulatory factors |
| Zdroj: | Journal of Virology. 91 |
| ISSN: | 1098-5514 0022-538X |
| DOI: | 10.1128/jvi.00312-17 |
| Popis: | Epstein-Barr virus (EBV) is associated with multiple human malignancies. EBV latent membrane protein 1 (LMP1) is required for the efficient transformation of primary B lymphocytes in vitro and possibly in vivo . The tumor suppressor p53 plays a seminal role in cancer development. In some EBV-associated cancers, p53 tends to be wild type and overly expressed; however, the effects of p53 on LMP1 expression is not clear. We find LMP1 expression to be associated with p53 expression in EBV-transformed cells under physiological and DNA damaging conditions. DNA damage stimulates LMP1 expression, and p53 is required for the stimulation. Ectopic p53 stimulates endogenous LMP1 expression. Moreover, endogenous LMP1 blocks DNA damage-mediated apoptosis. Regarding the mechanism of p53-mediated LMP1 expression, we find that interferon regulatory factor 5 (IRF5), a direct target of p53, is associated with both p53 and LMP1. IRF5 binds to and activates a LMP1 promoter reporter construct. Ectopic IRF5 increases the expression of LMP1, while knockdown of IRF5 leads to reduction of LMP1. Furthermore, LMP1 blocks IRF5-mediated apoptosis in EBV-infected cells. All of the data suggest that cellular p53 stimulates viral LMP1 expression, and IRF5 may be one of the factors for p53-mediated LMP1 stimulation. LMP1 may subsequently block DNA damage- and IRF5-mediated apoptosis for the benefits of EBV. The mutual regulation between p53 and LMP1 may play an important role in EBV infection and latency and its related cancers. IMPORTANCE The tumor suppressor p53 is a critical cellular protein in response to various stresses and dictates cells for various responses, including apoptosis. This work suggests that an Epstein-Bar virus (EBV) principal viral oncogene is activated by cellular p53. The viral oncogene blocks p53-mediated adverse effects during viral infection and transformation. Therefore, the induction of the viral oncogene by p53 provides a means for the virus to cope with infection and DNA damage-mediated cellular stresses. This seems to be the first report that p53 activates a viral oncogene; therefore, the discovery would be interesting to a broad readership from the fields of oncology to virology. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|